The Challenge of Change - Managing Excipients Control
Colorcon
13-Dec-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new chairman at PhRMA and appointments at McKesson, Elan and GeoVax.
09-Dec-2010 - US healthcare major J&J has launched a bid for Nertherlands-based Crucell, manufacturer of the PER.C6 biomanufacturing cell line.
09-Dec-2010 - Bulgarian drugmaker Sopharma will invest BGN70m ($47m) in the construction of a new manufacturing plant in a further bid to drive export growth.
07-Dec-2010 - Australian Pharmaceutical Industries (API) and Sigma Pharmaceuticals shares’ have been hit by Pfizer’s decision to abandon wholesale distributors in favour of selling drugs direct to pharmacies.
07-Dec-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new CEOs at Merck & Co and Pfizer.
06-Dec-2010 - WikiLeaks has published a list of overseas biopharmaceutical facilities considered vital to US national security as part of its release of leaked diplomatic cables.
06-Dec-2010 - GSK is close to buying Chinese-based specialist urology drugmaker Nanjing MeiRui Pharma according to various reports.
02-Dec-2010 - Only multiple anti-counterfeiting strategies are able to beat increasingly sophisticated criminals, according to a seminar on anti-counterfeiting at the recent AAPS trade event in New Orleans.
01-Dec-2010 - Pfizer will lay off 186 employees at its Vonore, US plant, as it intends to hand over the unit to the third-party logistics service provider, Exel, and outsource it logistics and distribution operations.
01-Dec-2010 - Novartis will reduce its US General Medicines sales force by 1,400 employees next year in preparation for impending patent loss for key products.
30-Nov-2010 - GSK has announced plans to invest £500m in its UK R&D and production operations with a particular focus on boosting biomanufacturing capacity.
30-Nov-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hospira, Celanese, Nycomed and Unigene Laboratories.
29-Nov-2010 - Pfizer has welcomed Government commitments to keep Ireland’s 12.5 per cent corporation tax rate in face of recent EU pressure to increase it as a condition of the €85bn 7-year IMF bailout.
29-Nov-2010 - Johnson & Johnson is recalling a further 9m Tylenol bottles in the US after learning of inconsistencies in product label warnings.
25-Nov-2010 - GlaxoSmithKline will sell its oral penicillin manufacturing facility in Tennessee, US, to Dr Reddy’s for an undisclosed sum, along with US rights to its Augmentin and Amoxin brands.
24-Nov-2010 - Camlin Fine Chemicals has been given the green light from its board of directors to acquire an unnamed Italian fine chemicals manufacturer and form a subsidiary company to help boost its presence in the Middle East.
24-Nov-2010 - ACTA was finalised last week but controversies remain, with research warning it could “create significant barriers to international trade, especially in generic medicines”.
23-Nov-2010 - Poor recruitment practices cost the United States pharmaceutical industry millions of dollars, warns a leading US biopharma recruitment agency.
23-Nov-2010 - Rumours suggest that Genzyme would consider accepting lower value takeover bids that take into account future performance of its cancer drug Campath in MS indications.
23-Nov-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Euthymics, CytomX, NPS Pharmaceuticals and InQ Biosciences.
22-Nov-2010 - Novartis aims to focus on the development of specialty medicines in a new long-term strategy to boost profitability in a rapidly changing healthcare environment.
22-Nov-2010 - Last week everything from co-processed excipients to Viagra-stuffed teddies were discussed at AAPS 2010. Now, with the show having finished, we present our personal take on the event.
18-Nov-2010 - Roche will cut 4,800 jobs worldwide over the next two years as part of a restructuring program designed to slash $2.4bn Swiss francs ($2.4bn) from annual costs.
17-Nov-2010 - IMS Health predicts China will become the world’s second largest pharmaceutical market by 2015 due to robust economic growth and healthcare reforms that allow for increased spending on drugs.
17-Nov-2010 - Spencer Pharmaceutical’s board of directors in favour of $0.97 per share buyout offer from anonymous buyer.